Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Pancreatic Cancer Stages UICC II-IV

NCT01448668 is registered in ClinicalTrials.gov with IFAG AG as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Pancreatic Cancer Stages UICC II-IV
Lead sponsor
IFAG AG
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
June 30, 2016
Enrollment
220 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer